Related Experiment Video
Updated: Jun 13, 2026

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
Bibliometric and visual analysis: A comprehensive tracking of global research trends on ablation and tumor immune
Sibo Meng1, Jiaxin Li1, Fangli Cao1
1Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, 758 Hefei Road, Qingdao, Shandong 266035, PR China.
Objective:
This study aims to gain an understanding the relationship between ablation and the tumor immune microenvironment. A bibliometric and visual analysis was conducted on relevant researches in this field over the past decade.
Materials And Methods:
As of February 21, 2026, the research team conducted a literature search using the Web of Science Core Collection (WoSCC) database. Two researchers independently carried out the search. After screening, a total of 5328 papers were selected for analysis. Citespace 6.4.R1, VOSviewer 1.6.18, and Bibliomatrix R software were used for bibliometric analysis and visualization.
Results:
An analysis of research on ablation and the tumor immune microenvironment from 2016 to 2025 shows that China leads the world in the number of published articles and has extensive international cooperation. Chinese research authors, highly cited articles, and research institutions have all performed outstandingly. The study also reviewed the literature on the synergistic effects of ablation and immunotherapy, indicating the dynamic changes in research hotspots in this field.
Conclusion:
The combination of immunotherapy and ablation is expected to become an effective treatment method for tumors. Ablation has evolved from local destruction to a core tumor treatment strategy that reshapes the immune microenvironment, and its combination with immunotherapy further demonstrates tremendous translational potential and clear clinical value.
Related Concept Videos
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
The Tumor Microenvironment
The Tumor Microenvironment
